Back to Search
ANDREW ARTZ, M.D., M.S.
M.D., M.S.
Hematology (Internal Medicine) Physician
NPI: 1306859772IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
36103920(IL)
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
C165285(CA)
Education
OTHER
Class of 1997
Research & Publications (20)
Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.
PMID 18940674·Biol Blood Marrow Transplant·2008
8-other
Separating correlation from prediction: C-reactive protein and infectious complications after chemotherapy for acute myeloid leukemia.
PMID 18297512·Leuk Lymphoma·2008
8-other
Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation.
PMID 16920562·Biol Blood Marrow Transplant·2006
3-trial
Order of patient entry influences outcome for metastatic renal cell cancer after non-myeloablative allogeneic stem cell transplantation.
PMID 16487176·Br J Haematol·2006
6-review
A phase II trial of sequential chemotherapy with docetaxel and methotrexate followed by gemcitabine and cisplatin for metastatic urothelial cancer.
PMID 15803001·Am J Clin Oncol·2005
3-trial
Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago Experience.
PMID 15543195·Bone Marrow Transplant·2005
3-trial
Pneumococcal vaccination and revaccination of older adults.
PMID 12692100·Clin Microbiol Rev·2003
6-review
BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants.
PMID 19660716·Biol Blood Marrow Transplant·2009
8-other
Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donors.
PMID 19539214·Biol Blood Marrow Transplant·2009
3-trial
Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes.
PMID 19361753·Biol Blood Marrow Transplant·2009
2-rct
Diminished quality of life and physical function in community-dwelling elderly with anemia.
PMID 19282701·Medicine (Baltimore)·2009
4-observational
Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia.
PMID 19142796·Leuk Lymphoma·2009
8-other
Immunity from smallpox vaccine persists for decades: a longitudinal study.
PMID 19028201·Am J Med·2008
8-other
Variation in supportive care practices in hematopoietic cell transplantation.
PMID 18940677·Biol Blood Marrow Transplant·2008
8-other
A population-based study of hemoglobin, race, and mortality in elderly persons.
PMID 18772477·J Gerontol A Biol Sci Med Sci·2008
8-other
Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options.
PMID 18640578·Biol Blood Marrow Transplant·2008
8-other
A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia.
PMID 18425419·Invest New Drugs·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 E DUARTE ROAD, MOB L001
DUARTE, CA 91010 - Phone
- (626) 256-4673
Quick Facts
- NPI
- 1306859772
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile